Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Pressure BioSciences, Inc. (PBIO) Announces Relocation to New Corporate Offices

Pressure BioSciences announced today that they have moved their offices in order to accommodate the transition from an early-stage research and development company to a fully commercial operation. The Company’s new address was provided as follows: 14 Norfolk Avenue in South Easton, Massachusetts 02375. While the corporate address was relocated, the Company’s primary research and development facility will continue to be located at 6 Gill Street in Woburn, MA.

“We now have approximately 5,500 square feet, with sufficient office, conference, engineering lab, and storage space to allow us to better develop our infrastructure to support our PCT product commercialization. In addition, the 18 month lease, with equal term extension, gives us the financial flexibility we require as we continue to grow our business and carefully manage our financial resources,” stated Richard T. Schumacher, Pressure BioSciences’ Founder, President, and CEO.

Pressure BioSciences is focused on developing Pressure Cycling Technology (PCT) which uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The technology has broad applications in the life sciences field including: genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification. The Company holds 13 US and 6 foreign patents that cover various PCT applications.

Let us hear your thoughts: Pressure BioSciences, Inc. Message Board

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *